Intrinsic Value of S&P & Nasdaq Contact Us

Nuvectis Pharma, Inc. NVCT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+14.5%

Stock Statistics — NVCT

Nuvectis Pharma, Inc. (NVCT) has a market capitalization of $231.27M and trades at $8.73. The 52-week range is 5.55-11.52.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.6, Earnings Per Share (EPS) of $-1.32.

The stock has a beta of -0.21, operates in the Healthcare sector.

Trading Data
Current Price$8.73
52-Week Range5.55-11.52
Volume43.83K
Avg Volume (30D)57.91K
Market Cap$231.27M
Beta (1Y)-0.21
Company
IPO Date2022-02-04
Employees13
CEORon Bentsur
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS67080T1088
CUSIP67080T108
Income (Latest Year)
EBITDA$-27.57M
Operating Income$-27.57M
Net Income$-26.44M
EPS$-1.32
EPS Diluted$-1.32
Shares Outstanding$21.81M
Balance Sheet (Latest Year)
Total Assets$31.71M
Current Assets$31.71M
Cash & ST Investments$31.63M
Total Liabilities$13.3M
Net Debt$-31.63M
Total Equity$18.41M
Valuation Ratios
P/E Ratio-6.6
P/B Ratio12.56
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message